Rhumbline Advisers Cor Medix Inc. Transaction History

Rhumbline Advisers

$121 Billion
Q3 2025

A detailed history of Rhumbline Advisers transactions in Cor Medix Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 95,552 shares of CRMD stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,552

Previous 92,905 2.85%

Holding current value

$1.08 Million

Previous $1.14 Million 0.09%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$10.07 - $14.83 $26,655 - $39,255	2,647 Added 2.85%	95,552 $1.14 Million
Q2 2025 Aug 12, 2025	BUY	$5.86 - $16.56 $66,452 - $187,790	11,340 Added 13.9%	92,905 $1.14 Million
Q1 2025 Apr 08, 2025	BUY	$6.16 - $12.57 $35,838 - $73,132	5,818 Added 7.68%	81,565 $529,000
Q4 2024 May 29, 2025	SELL	$8.1 - $13.59 $47,125 - $79,066	-5,818 Reduced 7.13%	75,747 $613,000
Q4 2024 Jan 30, 2025	BUY	$8.1 - $13.59 $48,826 - $81,920	6,028 Added 8.65%	75,747 $613,000

Q3 2024 Nov 12, 2024	SELL	$3.64 - $8.23 $16,452 - $37,199	-4,520 Reduced 6.09%	69,719 $563,000
Q2 2024 Aug 01, 2024	BUY	$4.08 - $6.39 $46,263 - $72,456	11,339 Added 18.03%	74,239 $321,000
Q1 2024 May 09, 2024	SELL	$2.94 - $4.24 $17,587 - $25,363	-5,982 Reduced 8.68%	62,900 $266,000
Q4 2023 Feb 08, 2024	BUY	$3.0 - $4.01 $36,558 - $48,865	12,186 Added 21.49%	68,882 $258,000
Q3 2023 Nov 09, 2023	BUY	$3.6 - $4.46 $25,707 - $31,848	7,141 Added 14.41%	56,696 $209,000
Q2 2023 Aug 08, 2023	BUY	$3.94 - $5.8 $195,246 - $287,419	49,555 New	49,555 $196,000
Q2 2022 Aug 11, 2022	SELL	$2.73 - $5.61 $115,563 - $237,476	-42,331 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$3.83 - $6.24 $3,898 - $6,352	-1,018 Reduced 2.35%	42,331 $232,000
Q4 2021 Feb 10, 2022	SELL	$4.47 - $5.56 $31 - $38	-7 Reduced 0.02%	43,349 $197,000
Q3 2021 Nov 12, 2021	BUY	$4.46 - $7.11 $1,413 - $2,253	317 Added 0.74%	43,356 $202,000
Q2 2021 Aug 05, 2021	BUY	$6.05 - $10.09 $111,852 - $186,543	18,488 Added 75.3%	43,039 $295,000
Q1 2021 May 06, 2021	SELL	$6.84 - $17.58 $12,790 - $32,874	-1,870 Reduced 7.08%	24,551 $245,000
Q4 2020 Feb 10, 2021	BUY	$5.0 - $9.15 $30,405 - $55,641	6,081 Added 29.9%	26,421 $196,000
Q3 2020 Nov 12, 2020	SELL	$3.96 - $6.15 $16,295 - $25,307	-4,115 Reduced 16.83%	20,340 $123,000
Q2 2020 Aug 13, 2020	BUY	$3.08 - $6.56 $15,378 - $32,754	4,993 Added 25.66%	24,455 $154,000
Q4 2019 Feb 05, 2020	BUY	$4.96 - $7.75 $654 - $1,023	132 Added 0.68%	19,462 $142,000
Q3 2019 Oct 23, 2019	BUY	$6.38 - $9.69 $4,657 - $7,073	730 Added 3.92%	19,330 $123,000
Q2 2019 Aug 14, 2019	BUY	$5.93 - $10.57 $110,298 - $196,602	18,600 New	18,600 $167,000

Others Institutions Holding CRMD

# of Institutions

204

Shares Held

41.2M

Call Options Held

1.33M

Put Options Held

1.3M

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $467M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Cor Medix Inc. Transaction History